Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginNet MarginOperating MarginReturn on Sales

Cogent Biosciences (COGT) FCF Margin (2017 - 2020)

Cogent Biosciences (COGT) has 3 years of FCF Margin data on record, last reported at 3290.71% in Q3 2020.

  • For Q3 2020, FCF Margin fell 229218.0% year-over-year to 3290.71%; the TTM value through Jun 2021 reached 13945.51%, down 1379945.0%, while the annual FY2025 figure was 8687.07%, N/A changed from the prior year.
  • FCF Margin reached 3290.71% in Q3 2020 per COGT's latest filing, down from 1576.52% in the prior quarter.
  • Across five years, FCF Margin topped out at 55.32% in Q4 2019 and bottomed at 3290.71% in Q3 2020.
  • Average FCF Margin over 3 years is 749.27%, with a median of 378.64% recorded in 2019.
  • The widest YoY moves for FCF Margin: up 26638bps in 2020, down -229218bps in 2020.
  • A 3-year view of FCF Margin shows it stood at 237.06% in 2018, then soared by 77bps to 55.32% in 2019, then crashed by -5848bps to 3290.71% in 2020.
  • Per Business Quant database, its latest 3 readings for FCF Margin were 3290.71% in Q3 2020, 1576.52% in Q2 2020, and 112.26% in Q1 2020.